James “Jim” Sigg FDA\'s Deputy Commissioner for Operations and Chief Operating Officer | Official Website
James “Jim” Sigg FDA\'s Deputy Commissioner for Operations and Chief Operating Officer | Official Website
This is a 200% increase over the number of companies inspected in the previous month, when one company was inspected through one inspection.
The companies inspected were involved in either the Biologics, Drugs, or Devices sectors.
There was one company in line with FDA regulations who don’t need to adjust their management operations or regulatory/administrative actions. Two should take voluntary action to correct the organization's management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Avioq, Inc. | Biologics | 12/05/2023 | Voluntary Action Indicated (VAI) |
Syneos Health | Drugs | 12/13/2023 | No Action Indicated (NAI) |
WatchChild, LLC | Devices | 12/13/2023 | Voluntary Action Indicated (VAI) |